CIK 0001000694 · Large accelerated filer
NOVAVAX INC
Sign in to watch- Ticker
- NVAX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 222816046
- Phone
- 240-268-2000
- Business address
- 21 FIRSTFIELD RD, GAITHERSBURG, MD
- POS AM Other Post-effective Amendment for Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Item 12 · Item 7
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Item 12 · Item 7
- 8-K Event Item 5 · Item 7
- 4 Insider Changes in Ownership
- 10-Q Report Quarterly Report
- 8-K Event Item 7 · Item 9
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- S-3 Offering Registration Statement
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
Page 77 of 83 · 1,649 filings